The solution helps advertisers improve media effectiveness through integrated pre-bid protection, AI-powered optimization and independent measurement NEW YORK, June 22, 2026 (GLOBE NEWSWIRE) — DoubleVerify (“DV”) (NYSE: DV), the leading software platform to verify media quality, optimize ad performance and prove campaign outcomes, today announced the expansion of DV Authentic AdVantage™ to Meta and TikTok. The solution combines pre-bid media quality protection, AI-powered campaign optimization and independent measurement, helping advertisers improve performance, strengthen media quality and drive greater efficiency across digital advertising environments. “Advertisers have been forced to choose between optimized cost efficiency and enhanced media quality for too long,” said Mark Zagorski, CEO of DoubleVerify. “DV Authentic...

Multi-year agreement brings Getty Images’ licensed content into OpenAI search and discovery experiences in ChatGPT NEW YORK, June 21, 2026 (GLOBE NEWSWIRE) — Getty Images (NYSE: GETY), a preeminent global visual content creator and marketplace, today announced a display agreement with OpenAI. Under the partnership Getty Images’ licensed content libraries will appear across OpenAI search and discovery experiences within ChatGPT. The agreement enables the use of Getty Images’ content for display within ChatGPT, enhancing the richness of visual responses. “High-quality, licensed visual content makes AI-powered search and discovery more useful and more trustworthy. This partnership with OpenAI reflects a shared recognition of that, and together we will deliver richer visual experiences to ChatGPT users,” said Craig Peters, Chief Executive...

Neither the Company nor its subsidiaries are under investigation by any regulator Urges CIRO to investigate potentially manipulative or deceptive trading activity in Abaxx’s common shares Retains leading U.S. law firm Paul, Weiss, Rifkind, Wharton & Garrison LLP to investigate wrongdoing by Viceroy and its affiliatesTORONTO, June 21, 2026 (GLOBE NEWSWIRE) —  Abaxx Technologies Inc. (TSX:ABXX)(OTCQX:ABXXF) (“Abaxx” or the “Company”), a financial software and market infrastructure company, majority shareholder of Abaxx Singapore Pte Ltd. (“Abaxx Singapore”), the owner of Abaxx Commodity Exchange and Clearinghouse (individually, “Abaxx Exchange” and “Abaxx Clearing”), today provided additional facts refuting ongoing misinformation published about the Company by Viceroy Research Group (“Viceroy”). Regulatory outreach and potential...

Results from the Phase 3 VELA clinical trials at Week 52 in adults with moderate-to-severe hidradenitis suppurativa (HS) demonstrate sonelokimab’s (SLK) potential best-in-class and best-in-disease profile, with consistent responses that are higher than those observed in trials of competing agents at the end of their respective parental trials Namely, ~67% of patients treated with SLK achieved HiSCR75 at the one-year mark, with more than one quarter of patients achieving inflammatory remission (IHS4-100), and around one third reaching HiSCR100 Patients treated with SLK likewise showed substantial improvement in HiSQOL at Week 52, with a mean score difference between end of trial and baseline of -15.0 points, indicating an average change from “severe” to “mild” impairment of the HS-related quality of life Almost half of the patients experienced...

KELLOGG, Idaho and VANCOUVER, British Columbia, June 19, 2026 (GLOBE NEWSWIRE) — Bunker Hill Mining Corp. (“Bunker Hill” or the “Company”) (TSX: BNKR | OTCQB: BHLL) is announcing that Mr. Mark Child has resigned from the Board of Directors of the Company, effective immediately. Mr. Child has served as a director of Bunker Hill since earlier this year, providing valuable guidance and oversight during a transformative period for the Company, including advancing and restarting the historic Bunker Hill Mine in Idaho. On behalf of the Board of Directors and management team, Sam Ash, Chief Executive Officer, stated: “We would like to thank Mark for his contributions and commitment to Bunker Hill over the years. His experience and perspective have been valuable as the Company advanced the redevelopment of the Bunker Hill Mine. We...

Amendment Provides Covenant Relief and Runway to Advance Its Strategic Review ROGERS, Ark., June 19, 2026 (GLOBE NEWSWIRE) — America’s Car-Mart, Inc. (NASDAQ: CRMT) (“Car-Mart” or the “Company”), today announced that it has entered into an amendment (the “Amendment”) to its Credit and Guaranty Agreement with Silver Point Finance, LLC, as Administrative Agent, and the Company’s lenders, as part of the Company’s proactive efforts to preserve liquidity and advance its ongoing strategic alternatives process. The Amendment provides the Company with covenant relief and a defined path forward as it works with its advisors to complete a review of strategic alternatives. A Special Committee of the Company’s Board of Directors will continue to actively evaluate the full range of strategic and financing alternatives available to the Company,...

MONTREAL, June 19, 2026 (GLOBE NEWSWIRE) — Dynacor Group Inc. (TSX: DNG) (“Dynacor” or the “Corporation”) is pleased to announce that at its annual general meeting of shareholders (AGM) held on June 19, 2026, all nominees listed in the management proxy circular were elected. Dynacor’s 2026 AGM also marked a leadership transition as COO Daniel Misiano was appointed President & CEO, succeeding long-serving CEO Jean Martineau who remains on the board as a director. 1.   Election of Directors The following persons have been elected as directors of Dynacor to hold office until the next annual meeting of shareholders, or until their successors are elected or appointed. Detailed results are as below:Nominee Votes For % For Votes Withheld % WithheldJean Martineau 18,609,401 77.34% 5,453,900 22.66%Pierre Béliveau 18,646,508 77.49% 5,416,793 22.51%Réjean...

CAMBRIDGE, Mass., June 19, 2026 (GLOBE NEWSWIRE) — CAMP4 Therapeutics Corporation (“CAMP4” or “the Company”) (Nasdaq: CAMP), a clinical-stage biopharmaceutical company developing a pipeline of regulatory RNA-targeting therapeutics designed to upregulate gene expression with the goal of restoring healthy protein levels to treat a broad range of genetic diseases, today announced that on June 15, 2026 (the “Grant Date”), the Compensation Committee of the Company’s Board of Directors granted non-qualified stock options to purchase an aggregate of 39,000 shares of the Company’s common stock to three newly hired employees of the Company, each as an inducement material to such employee’s entry into employment with the Company, in accordance with Nasdaq Listing Rule 5635(c)(4) (the “Inducement Grants”). The Inducement Grants each have...

VANCOUVER, British Columbia, June 19, 2026 (GLOBE NEWSWIRE) — Eupraxia Pharmaceuticals Inc. (“Eupraxia” or the “Company”) (TSX: EPRX) (NASDAQ: EPRX), a clinical-stage biotechnology company leveraging its proprietary Diffusphere™ technology designed to optimize local, controlled drug delivery for applications with significant unmet need, is pleased to announce the results from its Annual General Meeting of Shareholders (the “Meeting”) held on June 18, 2026. Pursuant to a resolution passed by ballot vote, all of the seven nominees proposed by management for election to the Company’s board of directors (the “Board”) at the Meeting and listed in the Company’s Management Information Circular dated May 11, 2026, were elected. The directors will remain in office until the next annual meeting of shareholders, or until their successors...